Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus sufentanil for recovery quality after ambulatory laparoscopic cholecystectomy
ChiCTR2500095986Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine and sufentanil in cholelithiasis, cholecystitis and gallbladder polyp (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Quality of Recovery-15 questionnaire score at 24 hours after surgery. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
cholelithiasischolecystitisgallbladder polyp
Beyond the preview
Go deeper on ChiCTR2500095986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095986.